Literature DB >> 15259902

Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide.

Uwe Cassens1, Wolfgang Göhde, Gudrun Kuling, Arndt Gröning, Peter Schlenke, Leopold Gustave Lehman, Yves Traoré, Jean Servais, Yvette Henin, Doris Reichelt, Burkhard Greve.   

Abstract

The determination of CD4 cells is of crucial clinical importance for patients with AIDS. However, the high costs involved represent limitations for CD4 cell counting in developing countries. In order to provide an affordable technique, we introduced a simplified volumetric counting (SVC) technique without sample manipulations and investigated it in a multicentre study. Blood samples from 434 healthy donors and immunodeficient patients were tested in eight hospital laboratories in Europe, Africa and Asia. CD4 cell counts were compared using in-house flow cytometric methods and the SVC technique. The SVC method was performed on a low-cost flow cytometer (CyFlow SL, Partec, Münster, Germany) after 15 min antibody incubation without pre-analytic manipulations, such as washing or erythrocyte lysing procedures. Linear regression analysis demonstrated a correlation of r=0.942 (Europe), r=0.952 (Africa) and r=0.989 (Asia) between the SVC technique and the in-house methods. Bland Altman plot analysis of all patient data showed a mean bias between the two methods of +26 CD4 cells in favour of the SVC technique (measured range: 6-1905 cells/microl; median CD4 cell count: 388/microl). Three centres used the FACS-count technique (Becton-Dickinson, San José, Calif., USA) as an in-house method dispensing with pre-analytic manipulations. The comparison of SVC and FACS-count method revealed a mean bias of +32 CD4 cells/microl (median CD4 cell count: 349/microl). The accuracy of the SVC was tested on standards with known CD4 cell counts (n=6) and was shown to be 95.2%. The low-cost device and the simplified no-lyse, no-wash test procedure reduces the costs per determination and facilitates the use of flow cytometry in developing countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259902

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  11 in total

Review 1.  Emerging technologies for point-of-care CD4 T-lymphocyte counting.

Authors:  David S Boyle; Kenneth R Hawkins; Matthew S Steele; Mitra Singhal; Xuanhong Cheng
Journal:  Trends Biotechnol       Date:  2011-07-26       Impact factor: 19.536

2.  Validation of a single-platform, volumetric, CD45-assisted PanLeucogating Auto40 flow cytometer to determine the absolute number and percentages of CD4 T cells in resource-constrained settings using Cameroonian patients' samples.

Authors:  François-Xavier Mbopi-Kéou; Stefano Mion; Bertrand Sagnia; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

3.  Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe.

Authors:  Justen Manasa; Hazvineyi Musabaike; Collen Masimirembwa; Eileen Burke; Ruedi Luthy; James Mudzori
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.

Authors:  Elijah Paintsil; Musie Ghebremichael; Sostena Romano; Warren A Andiman
Journal:  Pediatr Infect Dis J       Date:  2008-07       Impact factor: 2.129

5.  Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting.

Authors:  Lynn S Zijenah; Gerard Kadzirange; Simon Madzime; Margaret Borok; Chiedza Mudiwa; Ocean Tobaiwa; Mary Mucheche; Simbarashe Rusakaniko; David A Katzenstein
Journal:  J Transl Med       Date:  2006-08-14       Impact factor: 5.531

6.  T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years.

Authors:  Lynn S Zijenah; David A Katzenstein; Kusum J Nathoo; Simbarashe Rusakaniko; Ocean Tobaiwa; Christine Gwanzura; Arsene Bikoue; Margaret Nhembe; Petronella Matibe; George Janossy
Journal:  J Transl Med       Date:  2005-02-01       Impact factor: 5.531

7.  WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.

Authors:  Djibril Wade; Géraldine Daneau; Said Aboud; Gaby H Vercauteren; Willy S K Urassa; Luc Kestens
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

8.  Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the WHO recommendations for resource-constrained settings.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Ngamasra Nadjiouroum; Barou Djouater; Noël Djemadji-Oudjeil; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Res Notes       Date:  2013-04-30

9.  CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Makhtar Camara; Tandakha Ndiaye Dieye; Souleymane Mboup; Luc Kestens
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

10.  Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Barou Djouater; Noël Djemadji-Oudjeil; Francois-Xavier Mbopi-Keou; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Health Serv Res       Date:  2013-10-01       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.